Propolis Interacts with the Main Protease of SARS-CoV-2
An in silicon study conducted by Hashem and colleagues demonstrated that caffeic acid phenethyl ester, galangin, chrysin, and caffeic acid, all compounds that are found in propolis, are potential main protease inhibitors for SARS-CoV-2. The inhibition of the active site of the main protease of SARS-CoV-2 could theoretically act as an effective drug for SARS-CoV-2 treatment.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Propolis leads to reduction of pro-inflammatory cytokines
Propolis is an effective adjuvant therapy for multiple COVID-19 patient comorbidities
Propolis Interacts with the Main Protease of SARS-CoV-2
Propolis can Potentially Prevent SARS-CoV-2 from Binding to ACE2
The potential for kaempferol in propolis to treat COVID-19
Propolis blocks PAK-1 and and can contributes to alleviation of COVID-19 symptoms
Immunostimulatory Properties of Propolis
Propolis as a Potential COVID-19 Vaccine Adjuvant
Propolis Administration for COVID-19 Treatment and Prevention